CoM3D Limited

CoM3D is developing advanced therapeutic and immunologic delivery systems to address the future challenges in healthcare.

[CoM3D Limited @CoM3DLtd]

We are proud to announce that PharmE3D labs led by Assist. Prof. Maniruzzaman has recently earned several national and international #awards and #scholarships for outstanding research contributions to the field of #pharmaceutical #science and #technology.

https://t.co/triTZ6lRc9

[U.S. FDA @FDA]

You make look cool in them, but are they really protecting your eyes?

Make sure your sunglasses are more than just a fashion statement.

https://t.co/HWhRiorFth #UVSafetyAwarenessMonth

[TFF Pharmaceuticals, Inc. @TFFPharma]

#ICYMI: We’re working with Augmenta Bioworks to develop an inhalable #MonoclonalAntibody to treat #COVID19, which is stable at room temperature and in preclinical studies had activity against major variants of concern. Read more in BioPharma-Reporter: https://t.co/a8ZeuE6iWb

[CoM3D Limited @CoM3DLtd]

#3Dprinting is set to revolutionise the manufacture and delivery of #vaccines and #therapeutics. In this @ArmPharmRev article CoM3D’s Chief Scientific Advisor A. Prof. Mo Maniruzzaman discusses the paradigm shift in the way we approach treatment options
https://t.co/vIkxSzXkHV

[CoM3D Limited @CoM3DLtd]

#3Dprinting is set to revolutionise the manufacture and delivery of #vaccines and #therapeutics. In this @ArmPharmRev article CoM3D’s Chief Scientific Advisor A. Prof. Mo Maniruzzaman discusses the paradigm shift in the way we approach treatment options
https://t.co/vIkxSzXkHV

[CoM3D Limited @CoM3DLtd]

https://t.co/jhJPD8nHaC

[CoM3D Limited @CoM3DLtd]

https://t.co/aLjWwswZsM

[TFF Pharmaceuticals, Inc. @TFFPharma]

Check out CBS Austin’s article and video featuring TFF's Dr. Bill Williams speaking about TFF's technology and the COVID-19 vaccine. $TFFP's technology gives a solution to the ultra-cold temperatures needed to distribute the vaccine. Read more here: https://t.co/rNp2y1H0gx

[CoM3D Limited @CoM3DLtd]

Congratulations Rong!

[Bill Williams @BillTXCeutics]

Celebrate with Dr. Rong Cui @UTexasPharmacy @UTAustin as he receives "Fellow" status for his exceptional contributions. Congratulations Rong!! @AAPSComms

[Bill Williams @BillTXCeutics]

Collaborations are key! Significant milestone-more evidence that thin film freezing doesn't impact integrity of biologics-goal-minimize cold chain and enable alternative routes of delivery. @UTexasPharmacy @UTAustin @UTOTC @TFFPharma @universityofga https://t.co/HOjtV9BJWg

[Mo Maniruzzaman @MoManiruzzaman]

It’s an honour and true privilege to be on the Editorial Advisory Board of @pharmscitech @BillTXCeutics @UTexasPharmacy @UTAustin @AAPSComms @AapsChapter

[CoM3D Limited @CoM3DLtd]

@BillTXCeutics @MoManiruzzaman @pharmscitech @AAPSComms @UTexasPharmacy @UTAustin Congratulations Mo!

[Mo Maniruzzaman @MoManiruzzaman]

Integrated #algorithms led patient-focused #3dprinted tablets, a #QbD #DoE approach! We publish a ‘plug-and-play’ concept to optimise #dose without changing the formulations! Well done #PharmE3D #MPDD @UTexasPharmacy @UTAustin @AAPSComms @AapsChapter #AI https://t.co/rR3pGx93ip

[Advanced Material Development @AMDnanotech]

Great to be opening our new offices on the Surrey Research Park, Guildford.

[CoM3D Limited @CoM3DLtd]

@AdvMatDev And great to be with you.....!

[CoM3D Limited @CoM3DLtd]

CoM3D and University of Texas at Austin sign patent license agreement...
#3Dprinting #nanotechnology
https://t.co/sF8dwPHche

[CoM3D Limited @CoM3DLtd]

CoM3D Secures up to £1M in New Funding #3Dprinting #nanotechnology
https://t.co/HKoaWyoSAb